Skip to content

Correct Mobilization Time After Implantation of an Intracardiac Electronic Device Implantation

Safety and Benefits of Mobilization at 4 Hours Compared to 24 Hours After Implantation of an Intracardiac Electronic Device: a Randomized Clinical Trial of Non-inferiority, Open and Controlled in Parallel Groups

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06330675
Enrollment
558
Registered
2024-03-26
Start date
2023-02-01
Completion date
2027-06-01
Last updated
2025-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Defibrillators, Implantable, Pacemaker

Keywords

Pacemaker, Implantable cardioverter-defibrillator, Early mobilization, Bed-rest

Brief summary

Bedrest is usually prescribed for patients management after cardiac electronic device implantation (CIED) in order to prevent complication. Due to the lack of guidelines available on the timing of postoperative mobilization management, the aim of the study is to evaluate the safety of early mobilization, comparing mobilization at 4-h against day-after procedure.

Interventions

OTHEREarly mobilization

Short-term bed-rest and immobilization

OTHERStandard of care

Bed-rest and immobility until the day-after procedure

Sponsors

Cardiocentro Ticino
CollaboratorOTHER
Caporali Elena
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years old * Signed informed consent form * New permanent pacemaker implantation (PM) or implantable cardioverter-defibrillator (ICD)

Exclusion criteria

* CIED implants after recent cardiac surgery * Upgrade or revision of implanted device * CRT implantation * Intraoperative complications

Design outcomes

Primary

MeasureTime frameDescription
Composite endpoint: pacing lead dislodgement, pocket hematoma, pneumothorax, and pericardial effusionWithin 48 hours post operativeIncidence of post-operatory complications (composite endpoint). Non inferiority margin 5%

Secondary

MeasureTime frameDescription
Post-operative pain24 hoursPain will be assessed with the Numerical Rating Scale (NRS) scale ranging from 0 to 10 (0 corresponds to no pain and 10 to maximal level of pain).
Sleep disturbanceThe first night after surgeryQuality of sleep will be assessed using the Richards-Campbell Sleep Questionnaire (RCSQ), which ranges from 0 to 500 points, where 0 indicates the worst possible sleep quality and 500 the best possible. The sub-scores include sleep depth, sleep latency, number of awakenings, return to sleep after awakening, and overall sleep quality (each ranging from 0 to 100 points).
Number of participants with postoperative urinary retentionWithin 24 hours post operativeNumber of participants requiring an intervention such as a Foley catheter or catheterization
Number of participants developing orthostatic intoleranceFirst out-of-bed mobilizationNumber of participants who develop symptoms of orthostatic intolerance such as dizziness, nausea, vomiting, blurred vision, or syncope, during mobilization
Quality of recoveryDay 1Quality of recovery assessed with the Quality of recovery-15 (QoR-15) ranging from 0 (extremely poor quality of recovery) to 150 (excellent quality of recovery), and sub-scores (physical comfort 0-50, emotional state 0-40, psychological support 0-20, physical independence 0-20 and pain 0-20).
Number of participants developing pressure ulcerWithin 48 hours post operativeNumber of participants who develop pressure ulcers, assessed using Pressure Ulcer Classification System (stage 1, stage 2, stage 3, and stage 4)
Number of participants developing postoperative deliriumWithin 24 hours post operativeNumber of participants who develop postoperative delirium, as assessed by the 3-Minute Diagnostic Interview for Confusion Assessment Method (3D-CAM)

Other

MeasureTime frameDescription
Incidence of pacing lead dislodgement, pocket hematoma, pneumothorax, pericardial effusion, and pocket infection3 monthNumber of patients suffering with post-operatory complications

Countries

Switzerland

Contacts

Primary ContactElena Caporali, MD
elena.caporali@eoc.ch+41 (0)91 811 53 24
Backup ContactMichele Villa, RN
michele.villa@eoc.ch+41 (0)91 811 50 59

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026